EHR-to-EDC Success in a Complex Oncology, Adaptive Platform Trial
At OpenClinica, we are especially proud of the work we are doing with the I-SPY 2 Trial, sponsored and operated...
Case Study: I-SPY 2 Delivers Personalized Oncology Treatments Faster
As we wrote in our new case study, The I-SPY series of trials are reshaping the future of personalized oncology...
Oncology Clinical Trials Case Study: I-SPY 2 & OpenClinica
Without a doubt, oncology clinical trials are among the most complex and complicated trials. Two of the primary reasons are:...
Meet Some of OpenClinica’s Solutions Consultants
As a Solutions Consultant at OpenClinica, you will play a pivotal role in understanding the unique needs of our clients...
The Best of 2024: EHR to EDC eSource Integration Tops the List
Nearly eight months into 2024, it’s clear the OpenClinica community is most interested in reading about EHR to EDC eSource...
The Stakeholder Benefits of EHR eSource
At OpenClinica, we frequently write about the benefits of eSource EHR integration. That’s because it’s been, and continues to be,...
The Business Case for EHR eSource in Clinical Trials
How EHR eSource drives efficiencies across sites & sponsors In the words of one clinical research coordinator, “Entire Monday mornings...
12 Lessons Learned: How to Migrate Active Studies to a New EDC
ICYMI OpenClinica recently published a case study about our work with the Imperial College of London, Zero Interruptions: Migrating 14...
Zero Disruptions: Migrating 14 Mid-Study Clinical Trials in 16 Months
Mid-study data migrations are inherently complex, since any two electronic data capture (EDC) systems will have different ways of storing...








